Selective Inhibition of the Non-lysosomal Glucosylceramidase Gba2 and Elevation of Glucosylceramide in vivo: Consequences for Male Germ Cell Development

Selective Inhibition of the Non-lysosomal Glucosylceramidase Gba2 and Elevation of Glucosylceramide in vivo: Consequences for Male Germ Cell Development

Bibliographic Details
Main Authors:	van der Spoel, A, Platt, F
Format:	Conference item
Published:	2008

Similar Items

Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis.
by: Walden, C, et al.
Published: (2007)

The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction.
by: Platt, F, et al.
Published: (2012)

Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
by: Norris-Cervetto, E, et al.
Published: (2004)

Alkylated imino sugars, reversible male infertility-inducing agents, do not change the genetic integrity of male mouse germ cells, despite severe deformities of spermatozoal structures.
by: Suganuma, R, et al.
Published: (2004)

Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide.
by: D'Angelo, G, et al.
Published: (2007)

Alkylated imino sugars, reversible male infertility-inducing agents, do not affect the genetic integrity of male mouse germ cells during short-term treatment despite induction of sperm deformities.
by: Suganuma, R, et al.
Published: (2005)

Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
by: Butters, T, et al.
Published: (2000)

Glucosylceramide modulates membrane traffic along the endocytic pathway.
by: Sillence, D, et al.
Published: (2002)

Long-term non-hormonal male contraception in mice using N-butyldeoxynojirimycin.
by: Walden, C, et al.
Published: (2006)

Male germ cells require polyenoic sphingolipids with complex glycosylation for completion of meiosis: a link to ceramide synthase-3.
by: Rabionet, M, et al.
Published: (2008)

Glycosphingolipid changes in plasma in Parkinson’s disease independent of glucosylceramide levels
by: te Vruchte, D, et al.
Published: (2022)

Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases.
by: Lloyd-Evans, E, et al.
Published: (2011)

A monoclonal antibody to glucosylceramide inhibits the growth of Fonsecaea pedrosoi and enhances the antifungal action of mouse macrophages.
by: Nimrichter, L, et al.
Published: (2004)

New synthetic seven-membered 1-azasugars displaying potent inhibition towards glycosidases and glucosylceramide transferase.
by: Li, H, et al.
Published: (2008)

Lysosomal storage diseases
by: Platt, F, et al.
Published: (2018)

Characterization of glucosylceramides in Pseudallescheria boydii and their involvement in fungal differentiation.
by: Pinto, MR, et al.
Published: (2002)

Independent specialization of the human and mouse X chromosomes for the male germ line
by: Mueller, Jacob L., et al.
Published: (2014)

Emptying the stores: lysosomal diseases and therapeutic strategies
by: Platt, F
Published: (2017)

Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo
by: Khurana, V, et al.
Published: (2010)

Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo.
by: Khurana, V, et al.
Published: (2010)

ER stress and autophagic perturbations lead to elevated extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-derived dopamine neurons
by: Fernandes, H, et al.
Published: (2016)

Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses
by: Butters, T, et al.
Published: (2005)

GBA variants in REM sleep behavior disorder: A multicenter study
by: Krohn, L, et al.
Published: (2020)

Variant‐specific effects of GBA1 mutations on dopaminergic neuron proteostasis
by: Onal, G, et al.
Published: (2024)

Reversible infertility in male mice after oral administration of alkylated imino sugars: a nonhormonal approach to male contraception.
by: van der Spoel, A, et al.
Published: (2002)

Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy.
by: Platt, F, et al.
Published: (2001)

Molecular and regulatory profiling of murine transcription factor CTCFL in non-germ cells and male germline stem cells
by: Ab Samad, Maisarah
Published: (2022)

Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line.
by: Goriely, A, et al.
Published: (2003)

Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
by: Butters, T, et al.
Published: (2005)

Visual short-term memory deficits associated with GBA mutation and Parkinson's disease.
by: Zokaei, N, et al.
Published: (2014)

The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1
by: Gustavsson, EK, et al.
Published: (2024)

Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
by: Jeyakumar, M, et al.
Published: (2002)

Storage solutions: treating lysosomal disorders of the brain.
by: Jeyakumar, M, et al.
Published: (2005)

Good germs, bad germs: Citizen science and microbiology
by: Lorimer, J, et al.
Published: (2017)

Therapeutic applications of imino sugars in lysosomal storage disorders.
by: Butters, T, et al.
Published: (2003)

New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.
by: Butters, T, et al.
Published: (2003)

LYSOSOMAL SPHINGOSINE STORAGE INDUCED BY MYCOLIC ACID MEDIATED INHIBITION OF THE NPC1 PROTEIN IS CENTRAL TO Mycobacterium tuberculosis INDUCED PATHOGENESIS
by: Lloyd-Evans, E, et al.
Published: (2010)

c-Abl inhibition activates TFEB and promotes cellular clearance in a lysosomal disorder
by: Contreras, PS, et al.
Published: (2020)

Common and uncommon pathogenic cascades in lysosomal storage diseases.
by: Vitner, E, et al.
Published: (2010)

Treating lysosomal storage disorders: current practice and future prospects.
by: Platt, F, et al.
Published: (2009)